Lumenpulse Inc (LMPLF) 13.5178 $LMPLF Lumenpulse to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lumenpulse Inc (LMPLF) 13.5178 $LMPLF

Lumenpulse to Release Fourth Quarter and Fiscal 2016 Financial Results on June 22, 2016
Marketwired - Tue Jun 07, 10:01AM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 7, 2016) - Lumenpulse Inc. (TSX:LMP) will issue its fourth quarter and Fiscal 2016 financial results before the market opens on Wednesday, June 22, 2016. The Company will then hold an earnings conference call the same morning at 11:00 AM EDT, to discuss these results and answer analysts' questions.
LMP.TO: 17.00 (+0.10)

Lumenpulse Reports Fiscal 2016 Q3 Results
Marketwired - Thu Mar 10, 5:46AM CST
Lumenpulse Inc. (TSX: LMP), a leading manufacturer of high performance, specification-grade LED lighting solutions, released today its financial results for the third quarter and nine-month period ended January 31, 2016.
LMP.TO: 17.00 (+0.10)

Lumenpulse Acquires Fluxwerx Illumination
Marketwired - Thu Mar 10, 5:45AM CST
Lumenpulse Inc. (TSX: LMP) ("Lumenpulse", a leading manufacturer of high performance, specification-grade LED lighting solutions, announced today that it has acquired Fluxwerx Illumination Inc. ("Fluxwerx", a privately owned, fast growing, pure-play specification-grade LED lighting solutions provider based in British Columbia, Canada, for a total initial consideration of $60 million.
LMP.TO: 17.00 (+0.10)

Lumenpulse Acquires Italy-based Exenia
Marketwired - Thu Dec 17, 7:02AM CST
Note to Editors: There is a photo associated with this press release.
LMP.TO: 17.00 (+0.10)

Lumenpulse Reports Second Quarter of Fiscal 2016 Results
Marketwired - Thu Dec 10, 5:46AM CST
Lumenpulse Inc. (TSX: LMP)
LMP.TO: 17.00 (+0.10)

Lumenpulse Inc. to Issue Second Quarter Results for Fiscal 2016 on December 10, 2015
Marketwired - Tue Nov 24, 8:02AM CST
Lumenpulse Inc. (TSX: LMP) will issue its second quarter results for Fiscal 2016 before the market opens on Thursday, December 10th, 2015. The Company will then hold an earnings conference call the same morning at 11:00 AM EST to discuss these results and answer analysts' questions.
LMP.TO: 17.00 (+0.10)

Lumenpulse Added to the S&P/TSX Renewable Energy and Clean Technology Index
Marketwired - Mon Sep 21, 8:05AM CDT
Lumenpulse Inc. (TSX: LMP), a leading manufacturer of high performance, specification-grade LED lighting solutions, announced today that S&P Dow Jones Canadian Index Services has added Lumenpulse to the S&P/TSX Renewable Energy and Clean Technology Index. The Index measures the performance of companies listed on the TSX whose core business is the development of green technologies and sustainable infrastructure solutions
LMP.TO: 17.00 (+0.10)

Lumenpulse Added to the S&P/TSX Small Cap Index
Marketwired - Mon Sep 21, 8:02AM CDT
Lumenpulse Inc. (TSX: LMP), a leading manufacturer of high performance, specification-grade LED lighting solutions, announced today that it will be added to the S&P/TSX Small Cap Index, effective after the close of trading on Friday, September 18, 2015. S&P's Canadian Index Operations announced the addition on September 11, 2015, following their annual review of the S&P/TSX Small Cap Index.
LMP.TO: 17.00 (+0.10)

Lumenpulse Reports Voting Results
Marketwired - Tue Sep 15, 8:05AM CDT
Lumenpulse Inc. (TSX: LMP) ("Lumenpulse" or the "Company" held its annual meeting of shareholders in Montreal, Quebec, on Thursday, September 10, 2015 at the Montreal Science Center.
LMP.TO: 17.00 (+0.10)

REMINDER/Media Advisory: Lumenpulse Inc. Holds Annual Meeting of Shareholders Today
Marketwired - Thu Sep 10, 5:46AM CDT
Lumenpulse Inc. (TSX: LMP) will hold its Annual General Meeting of Shareholders today, September 10, 2015:
LMP.TO: 17.00 (+0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading